Osteoarthritis joint pain: The cytokine connection

Cytokine

Volumn 70, Issue 2, 2014, Pages 185-193

  Miller, Rachel E ^a   Miller, Richard J ^b   Malfait, Anne Marie ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Animal models; Chemokines; Cytokines; Osteoarthritis; Pain

Indexed keywords

ADALIMUMAB; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR2 ANTAGONIST; CHEMOKINE RECEPTOR CXCR4; CYTOKINE; FRACTALKINE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TUMOR NECROSIS FACTOR ALPHA;

ARTHRALGIA; DRUG EFFICACY; HUMAN; KNEE OSTEOARTHRITIS; NOCICEPTIVE STIMULATION; NONHUMAN; PAIN RECEPTOR; PAIN THRESHOLD; REVIEW; RHEUMATOID ARTHRITIS; SPINAL GANGLION; ANIMAL; CLINICAL TRIAL (TOPIC); IMMUNOLOGY; JOINT; METABOLISM; NOCICEPTION; OSTEOARTHRITIS; PAIN; PATHOLOGY;

ANIMALS; CLINICAL TRIALS AS TOPIC; CYTOKINES; HUMANS; JOINTS; NOCICEPTION; OSTEOARTHRITIS; PAIN;

EID: 84908323801     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2014.06.019     Document Type: Review

References (100)

1. Guccione A.A., Felson D.T., Anderson J.J., Anthony J.M., Zhang Y., Wilson P.W., et al. The effects of specific medical conditions on the functional limitations of elders in the Framingham study. Am J Public Health 1994, 84:351-358.
2. Cross M., Smith E., Hoy D., Nolte S., Ackerman I., Fransen M., et al. The global burden of hip and knee osteoarthritis: estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis 2014.
3. Loeser R.F., Goldring S.R., Scanzello C.R., Goldring M.B. Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum 2012, 64:1697-1707.
4. Malfait A.M., Schnitzer T.J. Towards a mechanism-based approach to pain management in osteoarthritis. Nat Rev Rheumatol 2013, 9:654-664.
5. Neogi T. The epidemiology and impact of pain in osteoarthritis. Osteoarthritis Cartilage/OARS, Osteoarthritis Res Soc 2013, 21:1145-1153.
6. Sellam J., Berenbaum F. The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nat Rev Rheumatol 2010, 6:625-635.
7. Scanzello C.R., Goldring S.R. The role of synovitis in osteoarthritis pathogenesis. Bone 2012, 51:249-257.
8. Brown T.D., Johnston R.C., Saltzman C.L., Marsh J.L., Buckwalter J.A. Posttraumatic osteoarthritis: a first estimate of incidence, prevalence, and burden of disease. J Orthop Trauma 2006, 20:739-744.
9. Olson S.A., Horne P., Furman B., Huebner J., Al-Rashid M., Kraus V.B., et al. The role of cytokines in posttraumatic arthritis. J Am Acad Orthop Surg 2014, 22:29-37.
10. Kapoor M., Martel-Pelletier J., Lajeunesse D., Pelletier J.P., Fahmi H. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol 2011, 7:33-42.
11. Jin X., Gereau R.W. Acute p38-mediated modulation of tetrodotoxin-resistant sodium channels in mouse sensory neurons by tumor necrosis factor-alpha. J Neurosci: Official J Soc For Neurosci 2006, 26:246-255.
12. Miller R.J., Jung H., Bhangoo S.K., White F.A. Cytokine and chemokine regulation of sensory neuron function. Handb Exp Pharmacol 2009, 417-449.
13. Schafers M., Lee D.H., Brors D., Yaksh T.L., Sorkin L.S. Increased sensitivity of injured and adjacent uninjured rat primary sensory neurons to exogenous tumor necrosis factor-alpha after spinal nerve ligation. J Neurosci: Official J Soc Forneurosci 2003, 23:3028-3038.
14. Opree A., Kress M. Involvement of the proinflammatory cytokines tumor necrosis factor-alpha, IL-1 beta, and IL-6 but not IL-8 in the development of heat hyperalgesia: effects on heat-evoked calcitonin gene-related peptide release from rat skin. J Neurosci: Official J Soc For Neurosci 2000, 20:6289-6293.
15. Hensellek S., Brell P., Schaible H.G., Brauer R., Segond von Banchet G. The cytokine TNFalpha increases the proportion of DRG neurones expressing the TRPV1 receptor via the TNFR1 receptor and ERK activation. Mol Cell Neurosci 2007, 36:381-391.
16. Ohtori S., Takahashi K., Moriya H., Myers R.R. TNF-alpha and TNF-alpha receptor type 1 upregulation in glia and neurons after peripheral nerve injury: studies in murine DRG and spinal cord. Spine 2004, 29:1082-1088.
17. Jung H., Miller R.J. Activation of the nuclear factor of activated T-cells (NFAT) mediates upregulation of CCR2 chemokine receptors in dorsal root ganglion (DRG) neurons: a possible mechanism for activity-dependent transcription in DRG neurons in association with neuropathic pain. Mol Cell Neurosci 2008, 37:170-177.
18. Shen K.F., Zhu H.Q., Wei X.H., Wang J., Li Y.Y., Pang R.P., et al. Interleukin-10 down-regulates voltage gated sodium channels in rat dorsal root ganglion neurons. Exp Neurol 2013, 247:466-475.
19. Stemkowski P.L., Smith P.A. Long-term IL-1beta exposure causes subpopulation-dependent alterations in rat dorsal root ganglion neuron excitability. J Neurophysiol 2012, 107:1586-1597.
20. von Banchet G.S., Fischer N., Uhlig B., Hensellek S., Eitner A., Schaible H.G. Molecular effects of interleukin-1beta on dorsal root ganglion neurons: prevention of ligand-induced internalization of the bradykinin 2 receptor and downregulation of G protein-coupled receptor kinase 2. Mol Cell Neurosci 2011, 46:262-271.
21. Ebbinghaus M., Uhlig B., Richter F., von Banchet G.S., Gajda M., Brauer R., et al. The role of interleukin-1beta in arthritic pain: main involvement in thermal, but not mechanical, hyperalgesia in rat antigen-induced arthritis. Arthritis Rheum 2012, 64:3897-3907.
22. Obreja O., Rathee P.K., Lips K.S., Distler C., Kress M. IL-1 beta potentiates heat-activated currents in rat sensory neurons: involvement of IL-1RI, tyrosine kinase, and protein kinase C. FASEB J: Official Publ Fed Am Soc Exp Biol 2002, 16:1497-1503.
23. Takeda M., Tanimoto T., Kadoi J., Nasu M., Takahashi M., Kitagawa J., et al. Enhanced excitability of nociceptive trigeminal ganglion neurons by satellite glial cytokine following peripheral inflammation. Pain 2007, 129:155-166.
24. Binshtok A.M., Wang H., Zimmermann K., Amaya F., Vardeh D., Shi L., et al. Nociceptors are interleukin-1beta sensors. J Neurosci: Official J Soc Neurosci 2008, 28:14062-14073.
25. Inoue A., Ikoma K., Morioka N., Kumagai K., Hashimoto T., Hide I., et al. Interleukin-1beta induces substance P release from primary afferent neurons through the cyclooxygenase-2 system. J Neurochem 1999, 73:2206-2213.
26. Li M., Shi J., Tang J.R., Chen D., Ai B., Chen J., et al. Effects of complete Freund's adjuvant on immunohistochemical distribution of IL-1beta and IL-1R I in neurons and glia cells of dorsal root ganglion. Acta Pharmacol Sin 2005, 26:192-198.
27. Safieh-Garabedian B., Poole S., Allchorne A., Winter J., Woolf C.J. Contribution of interleukin-1 beta to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia. Br J Pharmacol 1995, 115:1265-1275.
28. Zhang X., Huang J., McNaughton P.A. NGF rapidly increases membrane expression of TRPV1 heat-gated ion channels. EMBO J 2005, 24:4211-4223.
29. Seidel M.F., Wise B.L., Lane N.E. Nerve growth factor: an update on the science and therapy. Osteoarthritis Cartilage/OARS, Osteoarthritis Res Soc 2013, 21:1223-1228.
30. Taga T., Kishimoto T. Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol 1997, 15:797-819.
31. von Banchet G.S., Kiehl M., Schaible H.G. Acute and long-term effects of IL-6 on cultured dorsal root ganglion neurones from adult rat. J Neurochem 2005, 94:238-248.
32. Obreja O., Biasio W., Andratsch M., Lips K.S., Rathee P.K., Ludwig A., et al. Fast modulation of heat-activated ionic current by proinflammatory interleukin 6 in rat sensory neurons. Brain: J Neurol 2005, 128:1634-1641.
33. Obreja O., Schmelz M., Poole S., Kress M. Interleukin-6 in combination with its soluble IL-6 receptor sensitises rat skin nociceptors to heat, in vivo. Pain 2002, 96:57-62.
34. Andratsch M., Mair N., Constantin C.E., Scherbakov N., Benetti C., Quarta S., et al. A key role for gp130 expressed on peripheral sensory nerves in pathological pain. J Neurosci: Official J Soc Neurosci 2009, 29:13473-13483.
35. Quarta S., Vogl C., Constantin C.E., Uceyler N., Sommer C., Kress M. Genetic evidence for an essential role of neuronally expressed IL-6 signal transducer gp130 in the induction and maintenance of experimentally induced mechanical hypersensitivity in vivo and in vitro. Mol Pain 2011, 7:73.
36. Richter F., Natura G., Ebbinghaus M., von Banchet G.S., Hensellek S., Konig C., et al. Interleukin-17 sensitizes joint nociceptors to mechanical stimuli and contributes to arthritic pain through neuronal interleukin-17 receptors in rodents. Arthritis Rheum 2012, 64:4125-4134.
37. von Banchet G. Segond, Boettger M.K., Konig C., Iwakura Y., Brauer R., Schaible H.G. Neuronal IL-17 receptor upregulates TRPV4 but not TRPV1 receptors in DRG neurons and mediates mechanical but not thermal hyperalgesia. Mol Cell Neurosci 2013, 52:152-160.
38. Song P., Zhao Z.Q., Liu X.Y. Expression of IL-2 receptor in dorsal root ganglion neurons and peripheral antinociception. NeuroReport 2000, 11:1433-1436.
39. Yao M.Z., Gu J.F., Wang J.H., Sun L.Y., Lang M.F., Liu J., et al. Interleukin-2 gene therapy of chronic neuropathic pain. Neuroscience 2002, 112:409-416.
40. Cata J.P., Weng H.R., Dougherty P.M. Spinal injection of IL-2 or IL-15 alters mechanical and thermal withdrawal thresholds in rats. Neurosci Lett 2008, 437:45-49.
41. Austin P.J., Moalem-Taylor G. The neuro-immune balance in neuropathic pain: involvement of inflammatory immune cells, immune-like glial cells and cytokines. J Neuroimmunol 2010, 229:26-50.
42. Gomez-Nicola D., Valle-Argos B., Suardiaz M., Taylor J.S., Nieto-Sampedro M. Role of IL-15 in spinal cord and sciatic nerve after chronic constriction injury: regulation of macrophage and T-cell infiltration. J Neurochem 2008, 107:1741-1752.
43. Milligan E.D., Langer S.J., Sloane E.M., He L., Wieseler-Frank J., O'Connor K., et al. Controlling pathological pain by adenovirally driven spinal production of the anti-inflammatory cytokine, interleukin-10. Eur J Neurosci 2005, 21:2136-2148.
44. Dawes J.M., McMahon S.B. Chemokines as peripheral pain mediators. Neurosci Lett 2013, 557:Pt A:1-Pt A:8.
45. Oh S.B., Tran P.B., Gillard S.E., Hurley R.W., Hammond D.L., Miller R.J. Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons. J Neurosci: Official J Soc Neurosci 2001, 21:5027-5035.
46. White F.A., Sun J., Waters S.M., Ma C., Ren D., Ripsch M., et al. Excitatory monocyte chemoattractant protein-1 signaling is up-regulated in sensory neurons after chronic compression of the dorsal root ganglion. Proc Natl Acad Sci USA 2005, 102:14092-14097.
47. Sun J.H., Yang B., Donnelly D.F., Ma C., LaMotte R.H. MCP-1 enhances excitability of nociceptive neurons in chronically compressed dorsal root ganglia. J Neurophysiol 2006, 96:2189-2199.
48. Belkouch M., Dansereau M.A., Reaux-Le Goazigo A., Van Steenwinckel J., Beaudet N., Chraibi A., et al. The chemokine CCL2 increases Nav1.8 sodium channel activity in primary sensory neurons through a Gbetagamma-dependent mechanism. J Neurosci: Official J Soc Neurosci 2011, 31:18381-18390.
49. Kao D.J., Li A.H., Chen J.C., Luo R.S., Chen Y.L., Lu J.C., et al. CC chemokine ligand 2 upregulates the current density and expression of TRPV1 channels and Nav1.8 sodium channels in dorsal root ganglion neurons. J Neuroinflammation 2012, 9:189.
50. Abbadie C., Lindia J.A., Cumiskey A.M., Peterson L.B., Mudgett J.S., Bayne E.K., et al. Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2. Proc Natl Acad Sci USA 2003, 100:7947-7952.
51. Jung H., Bhangoo S., Banisadr G., Freitag C., Ren D., White F.A., et al. Visualization of chemokine receptor activation in transgenic mice reveals peripheral activation of CCR2 receptors in states of neuropathic pain. J Neurosci: Official J Soc Neurosci 2009, 29:8051-8062.
52. Garton K.J., Gough P.J., Blobel C.P., Murphy G., Greaves D.R., Dempsey P.J., et al. Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). J Biol Chem 2001, 276:37993-38001.
53. Hundhausen C., Schulte A., Schulz B., Andrzejewski M.G., Schwarz N., von Hundelshausen P., et al. Regulated shedding of transmembrane chemokines by the disintegrin and metalloproteinase 10 facilitates detachment of adherent leukocytes. J Immunol (Baltimore, Md: 1950) 2007, 178:8064-8072.
54. Tsou C.L., Haskell C.A., Charo I.F. Tumor necrosis factor-alpha-converting enzyme mediates the inducible cleavage of fractalkine. J Biol Chem 2001, 276:44622-44626.
55. Clark A.K., Yip P.K., Grist J., Gentry C., Staniland A.A., Marchand F., et al. Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain. Proc Natl Acad Sci USA 2007, 104:10655-10660.
56. Mizutani M., Pino P.A., Saederup N., Charo I.F., RansohoffR.M., Cardona A.E. The fractalkine receptor but not CCR2 is present on microglia from embryonic development throughout adulthood. J Immunol 2012, 188:29-36.
57. Clark A.K., Yip P.K., Malcangio M. The liberation of fractalkine in the dorsal horn requires microglial cathepsin S. J Neurosci: Official J Soc Neurosci 2009, 29:6945-6954.
58. Richter F., Natura G., Loser S., Schmidt K., Viisanen H., Schaible H.G. Tumor necrosis factor causes persistent sensitization of joint nociceptors to mechanical stimuli in rats. Arthritis Rheum 2010, 62:3806-3814.
59. Konig C., Zharsky M., Moller C., Schaible H.G., Ebersberger A. Involvement of peripheral and spinal tumor necrosis factor alpha in spinal cord hyperexcitability during knee joint inflammation in rats. Arthritis Rheumatol 2014, 66:599-609.
60. Brenn D., Richter F., Schaible H.G. Sensitization of unmyelinated sensory fibers of the joint nerve to mechanical stimuli by interleukin-6 in the rat: an inflammatory mechanism of joint pain. Arthritis Rheum 2007, 56:351-359.
61. Vazquez E., Kahlenbach J., von Banchet G. Segond, Konig C., Schaible H.G., Ebersberger A. Spinal interleukin-6 is an amplifier of arthritic pain in the rat. Arthritis Rheum 2012, 64:2233-2242.
62. McNearney T., Baethge B.A., Cao S., Alam R., Lisse J.R., Westlund K.N. Excitatory amino acids, TNF-alpha, and chemokine levels in synovial fluids of patients with active arthropathies. Clin Exp Immunol 2004, 137:621-627.
63. Lawand N.B., Willis W.D., Westlund K.N. Excitatory amino acid receptor involvement in peripheral nociceptive transmission in rats. Eur J Pharmacol 1997, 324:169-177.
64. Brackertz D., Mitchell G.F., Mackay I.R. Antigen-induced arthritis in mice. I. Induction of arthritis in various strains of mice. Arthritis Rheum 1977, 20:841-850.
65. Boettger M.K., Hensellek S., Richter F., Gajda M., Stockigt R., von Banchet G.S., et al. Antinociceptive effects of tumor necrosis factor alpha neutralization in a rat model of antigen-induced arthritis: evidence of a neuronal target. Arthritis Rheum 2008, 58:2368-2378.
66. von Banchet G. Segond, Boettger M.K., Fischer N., Gajda M., Brauer R., Schaible H.G. Experimental arthritis causes tumor necrosis factor-alpha-dependent infiltration of macrophages into rat dorsal root ganglia which correlates with pain-related behavior. Pain 2009, 145:151-159.
67. Boettger M.K., Leuchtweis J., Kummel D., Gajda M., Brauer R., Schaible H.G. Differential effects of locally and systemically administered soluble glycoprotein 130 on pain and inflammation in experimental arthritis. Arthritis Res Ther 2010, 12:R140.
68. Pinto L.G., Cunha T.M., Vieira S.M., Lemos H.P., Verri W.A., Cunha F.Q., et al. IL-17 mediates articular hypernociception in antigen-induced arthritis in mice. Pain 2010, 148:247-256.
69. Bonnet C.S., Williams A.S., Gilbert S.J., Harvey A.K., Evans B.A., Mason D.J. AMPA/kainate glutamate receptors contribute to inflammation, degeneration and pain related behaviour in inflammatory stages of arthritis. Ann Rheum Dis 2013.
70. Malfait A.M., Little C.B., McDougall J.J. A commentary on modelling osteoarthritis pain in small animals. Osteoarthritis Cartilage/OARS, Osteoarthritis Res Soc 2013, 21:1316-1326.
71. Glasson S.S., Blanchet T.J., Morris E.A. The surgical destabilization of the medial meniscus (DMM) model of osteoarthritis in the 129/SvEv mouse. Osteoarthritis Cartilage/OARS, Osteoarthritis Res Soc 2007, 15:1061-1069.
72. Malfait A.M., Ritchie J., Gil A.S., Austin J.S., Hartke J., Qin W., et al. ADAMTS-5 deficient mice do not develop mechanical allodynia associated with osteoarthritis following medial meniscal destabilization. Osteoarthritis Cartilage/OARS, Osteoarthritis Res Soc 2010, 18:572-580.
73. Miller R.E., Tran P.B., Das R., Ghoreishi-Haack N., Ren D., Miller R.J., et al. CCR2 chemokine receptor signaling mediates pain in experimental osteoarthritis. Proc Natl Acad Sci USA 2012, 109:20602-20607.
74. Inglis J.J., McNamee K.E., Chia S.L., Essex D., Feldmann M., Williams R.O., et al. Regulation of pain sensitivity in experimental osteoarthritis by the endogenous peripheral opioid system. Arthritis Rheum 2008, 58:3110-3119.
75. McNamee K.E., Burleigh A., Gompels L.L., Feldmann M., Allen S.J., Williams R.O., et al. Treatment of murine osteoarthritis with TrkAd5 reveals a pivotal role for nerve growth factor in non-inflammatory joint pain. Pain 2010, 149:386-392.
76. Burleigh A., Chanalaris A., Gardiner M.D., Driscoll C., Boruc O., Saklatvala J., et al. Joint immobilization prevents murine osteoarthritis and reveals the highly mechanosensitive nature of protease expression in vivo. Arthritis Rheum 2012, 64:2278-2288.
77. Miller R.E., Tran P., Ghoreishi-Haack N., Das R., Malfait A.M. A role for chemokines and NGF in pain generation in a murine model of osteoarthritis. Osteoarthritis Cartilage 2011, S7-S52.
78. Dawes J.M., Kiesewetter H., Perkins J.R., Bennett D.L., McMahon S.B. Chemokine expression in peripheral tissues from the monosodium iodoacetate model of chronic joint pain. Molecular Pain 2013, 9:57.
79. Beekhuizen M., Gierman L.M., van Spil W.E., Van Osch G.J., Huizinga T.W., Saris D.B., et al. An explorative study comparing levels of soluble mediators in control and osteoarthritic synovial fluid. Osteoarthritis Cartilage/OARS, Osteoarthritis Res Soc 2013, 21:918-922.
80. Kanbe K., Takagishi K., Chen Q. Stimulation of matrix metalloprotease 3 release from human chondrocytes by the interaction of stromal cell-derived factor 1 and CXC chemokine receptor 4. Arthritis Rheum 2002, 46:130-137.
81. Ruth J.H., Volin M.V., Haines G.K., WoodruffD.C., Katschke K.J., Woods J.M., et al. Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis. Arthritis Rheum 2001, 44:1568-1581.
82. McNearney T., Speegle D., Lawand N., Lisse J., Westlund K.N. Excitatory amino acid profiles of synovial fluid from patients with arthritis. J Rheumatol 2000, 27:739-745.
83. Orita S., Koshi T., Mitsuka T., Miyagi M., Inoue G., Arai G., et al. Associations between proinflammatory cytokines in the synovial fluid and radiographic grading and pain-related scores in 47 consecutive patients with osteoarthritis of the knee. BMC Musculoskeletal Disorders 2011, 12:144.
84. Cuellar J.M., Scuderi G.J., Cuellar V.G., Golish S.R., Yeomans D.C. Diagnostic utility of cytokine biomarkers in the evaluation of acute knee pain. J Bone Joint Surg Am Vol 2009, 91:2313-2320.
85. Chevalier X., Eymard F., Richette P. Biologic agents in osteoarthritis: hopes and disappointments. Nat Rev Rheumatol 2013, 9:400-410.
86. Maksymowych W.P., Russell A.S., Chiu P., Yan A., Jones N., Clare T., et al. Targeting tumour necrosis factor alleviates signs and symptoms of inflammatory osteoarthritis of the knee. Arthritis Res Ther 2012, 14:R206.
87. Chevalier X., Ravaud P., Maheu E., Baron G., Rialland A., Vergnaud P., et al. A randomized, multicentre, double blind, placebo-controlled trial of anti TNF alpha (adalimumab) in refractory hand osteoarthritis: the Dora study. Arthritis Rheumatol 2012, 64:2472.
88. Chevalier X., Goupille P., Beaulieu A.D., Burch F.X., Bensen W.G., Conrozier T., et al. Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum 2009, 61:344-352.
89. Kraus V.B., Birmingham J., Stabler T.V., Feng S., Taylor D.C., Moorman C.T., et al. Effects of intraarticular IL1-Ra for acute anterior cruciate ligament knee injury: a randomized controlled pilot trial (NCT00332254). Osteoarthritis Cartilage/OARS, Osteoarthritis Res Soc 2012, 20:271-278.
90. Xue C.-B., Wang A., Han Q., Zhang Y., Cao G., Feng H., et al. Discovery of INCB8761/PF-4136309, a potent, selective, and orally bioavailable CCR2 antagonist. ACS Med Chem Lett 2011, 2:913-918.
91. Williams R.O., Paleolog E., Feldmann M. Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases. Curr Opin Pharmacol 2007, 7:412-417.
92. Hess A., Axmann R., Rech J., Finzel S., Heindl C., Kreitz S., et al. Blockade of TNF-alpha rapidly inhibits pain responses in the central nervous system. Proc Natl Acad Sci USA 2011, 108:3731-3736.
93. Schaible H.G., Grubb B.D. Afferent and spinal mechanisms of joint pain. Pain 1993, 55:5-54.
94. Bjurholm A., Kreicbergs A., Ahmed M., Schultzberg M. Noradrenergic and peptidergic nerves in the synovial membrane of the Sprague-Dawley rat. Arthritis Rheum 1990, 33:859-865.
95. Gronblad M., Konttinen Y.T., Korkala O., Liesi P., Hukkanen M., Polak J.M. Neuropeptides in synovium of patients with rheumatoid arthritis and osteoarthritis. J Rheumatol 1988, 15:1807-1810.
96. Kruger L., Silverman J.D., Mantyh P.W., Sternini C., Brecha N.C. Peripheral patterns of calcitonin-gene-related peptide general somatic sensory innervation: cutaneous and deep terminations. J Comp Neurol 1989, 280:291-302.
97. Mapp P.I., Kidd B.L., Gibson S.J., Terry J.M., Revell P.A., Ibrahim N.B., et al. Substance P-, calcitonin gene-related peptide- and C-flanking peptide of neuropeptide Y-immunoreactive fibres are present in normal synovium but depleted in patients with rheumatoid arthritis. Neuroscience 1990, 37:143-153.
98. Pereira da Silva J.A., Carmo-Fonseca M. Peptide containing nerves in human synovium: immunohistochemical evidence for decreased innervation in rheumatoid arthritis. J Rheumatol 1990, 17:1592-1599.
99. Eitner A., Pester J., Nietzsche S., Hofmann G.O., Schaible H.G. The innervation of synovium of human osteoarthritic joints in comparison with normal rat and sheep synovium. Osteoarthritis Cartilage/OARS, Osteoarthritis Res Soc 2013, 21:1383-1391.
100. Mapp P.I., Walsh D.A. Mechanisms and targets of angiogenesis and nerve growth in osteoarthritis. Nat Rev Rheumatol 2012, 8:390-398.